Leukaemia, acute myeloid - Treatment 

Treating acute myeloid leukaemia 

Cancer treatment: coping with hair loss during chemotherapy

Hair loss is a potential side effect of chemotherapy. Jessica, who was diagnosed with breast cancer in 2009, talks about her experience with chemotherapy and describes how the hair loss affected her. Also, an expert gives advice on how to cope with hair loss and where to find support.

Your care team

The treatment team will often include:

  • a haemato-oncologist (a specialist in the non-surgical treatment of leukaemia using techniques such as chemotherapy)
  • a haemato-pathologist (a specialist in the study of cancerous blood cells)
  • a paediatrician (a doctor who specialises in treating children)
  • a pharmacist
  • a social worker
  • a psychologist
  • a specialist cancer nurse (who will serve as the first point of contact between yourself and the members of the care team)
  • a counsellor

Clinical trials

In the UK, a number of clinical trials are currently underway that aim to find the best way of treating acute leukaemia. Clinical trials are studies that use new and experimental techniques to see how well they work in treating and possibly curing acute leukaemia.

However, you should be aware that there is no guarantee that the techniques that are being studied in the clinical trial will be more effective than current treatments.

Search for clinical trials on acute myeloid leukaemia

Your care team will also be able to let you know whether there are any clinical trials available in your area, as well as explaining the benefits and risks involved.

As acute myeloid leukaemia is an aggressive condition that develops rapidly, treatment will usually begin a few days after a diagnosis has been made.

Because of the often complex nature of acute myeloid leukaemia, the condition is usually treated by a team of different specialists working together. This type of team is known as a multidisciplinary team (see box, left).

Stages of treatment

Treatment for acute myeloid leukaemia is carried out in two stages:

  • Induction – the aim of the initial stage of treatment is to kill the leukaemia cells in your bone marrow, restore your blood to proper working order and treat any symptoms that you may have.
  • Consolidation – this stage aims to kill any remaining leukaemia cells that may be present in your central nervous system.

Induction

The induction stage of treatment is carried out in hospital or in a specialist centre. This is because you will probably need to have regular blood transfusions as it is likely that your blood will not contain enough healthy blood cells.

You will also be vulnerable to infection, so it is important that you are in a sterile environment where your health can be carefully monitored and any infection that you have can be promptly treated. You may also be prescribed antibiotics to help prevent further infection.

Chemotherapy

You will be given a combination of chemotherapy medication to kill the leukaemia cells in your bone marrow. As you will need to have many medicines as part of your treatment, a tube will be inserted into a large vein near your heart. This is known as a central line. Having a central line means you will not need to have many painful injections.

Some chemotherapy medication may also be directly administered into your cerebrospinal fluid to kill any leukaemia cells that may have spread to your nervous system. This is given using a needle that is placed into your spine, in a similar way to a lumbar puncture.

Side effects that occur following chemotherapy are common. They can include:

  • nausea
  • vomiting
  • diarrhoea
  • loss of appetite
  • mouth ulcers
  • tiredness
  • skin rashes
  • infertility
  • hair loss

The side effects should resolve once treatment has finished. Your hair will usually take between three to six months to grow back.

All trans retinoic acid (ATRA)

If you have the sub-type of acute myeloid leukaemia known as acute promyelocytic leukaemia, you will usually also be given a medicine called all trans retinoic acid (ATRA). ATRA works by changing the immature blast cells into mature healthy blood cells, and can reduce symptoms very quickly.

Side effects of ATRA include:

  • headaches
  • dry mouth and skin
  • nausea
  • bone pain
  • dry eyes

Depending on how well you respond to treatment, the induction phase can last from two weeks to several months. In some cases, you or your child may be able to leave hospital and receive treatment on an outpatient basis if your symptoms improve.

Consolidation

Leukaemia can return if just one cancerous cell remains in your body. Therefore the aim of consolidation treatment is to ensure that any remaining leukaemia cells are killed.

Treatment involves receiving regular injections of chemotherapy medication. This is usually done on an outpatient basis, which means that you will not have to stay in hospital overnight. However, you may require some short stays in hospital if your symptoms suddenly get worse or if you develop an infection.

The consolidation phase of treatment lasts several months.

Other treatments

There are a number of other treatments that are used in some circumstances. These are described below. 

Radiotherapy

Radiotherapy involves using high doses of controlled radiation to kill cancerous cells. There are two main reasons why radiotherapy is usually used to treat acute leukaemia:

  • to treat advanced cases of acute myeloid leukaemia that have spread to the nervous system and/or brain
  • to prepare the body for a bone marrow transplant (see below)

Side effects of both types of radiotherapy include:

  • hair loss
  • nausea
  • fatigue

The side effects should pass once your course of radiotherapy has been completed. Read more about radiotherapy.

Bone marrow and stem cell transplants

If you or your child do not respond to chemotherapy, a possible alternative treatment option is bone marrow or stem cell transplantation.

Before transplantation can take place, the person receiving the transplant will need to have aggressive high-dose chemotherapy and radiotherapy to destroy any cancerous cells in their body. This can put an enormous amount strain on the body and cause significant side effects and potential complications.

Transplantations have better outcomes if the donor has the same tissue type as the person who is receiving the donation. The best candidate to provide a donation is usually a brother or sister with the same tissue type.

Due to these issues, transplantations are usually only successful when they are carried out in children and young people, or older people who are in good health, and when there is a suitable donor, such as a brother or sister.

Read about Bone marrow transplantation for more information.

Newer unlicensed treatments

If you take part in a clinical trial (see box on this page), you may be offered a drug that is not licensed for use in the UK for acute myeloid leukaemia and is not normally available. Macmillan has information about unlicensed treatments for acute myeloid leukaemia.

Last reviewed: 01/06/2012

Next review due: 01/06/2014

Ratings

How helpful is this page?

Average rating

Based on 14 ratings

All ratings

Add your rating

Comments are personal views. Any information they give has not been checked and may not be accurate.

Haematologist said on 01 August 2011

Use of dasatinib is incredibly rare - doesnt deserve the amount of space given to it here

Report this content as offensive or unsuitable